Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 48Neoplasms 43Depression 31Fatigue 30Prostatic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Follicular 18Lymphoma, Large B-Cell, Diffuse 17Multiple Myeloma 16Carcinoma, Non-Small-Cell Lung 16Lymphoma, Non-Hodgkin 15Lung Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Hodgkin Disease 14Colorectal Neoplasms 14Burkitt Lymphoma 14Anxiety Disorders 14Pain 13Lymphoma, B-Cell, Marginal Zone 13Lymphoma, Large-Cell, Immunoblastic 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Head and Neck Neoplasms 11Blast Crisis 11Lymphoma, T-Cell, Cutaneous 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Hairy Cell 10

Interventions

Therapeutics 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FAP- Expressing Positive Tumors × Therapeutics × Clear all
NCT06638034 2024-10-15

Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
15 enrolled

FAP- Expressing Positive Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡